Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Third Wave Therapeutics121 enrolled

Overview

Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion

This is an interventional study designed to gather data on real world utilization of Acoustic Resonance Therapy for treating moderate to severe nasal congestion

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

121

Conditions

Nasal Congestion

Interventions

Sonu Acoustic Resonance TherapyDEVICE

Participants will receive Sonu treatment twice a day for 90 days

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age and older * Present with symptoms of chronic nasal congestion * Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening Exclusion Criteria: * Head, nasal or sinus surgery within 3 months * Pregnancy

Locations (1)

San Francisco Otolaryngology Medical Group

San Francisco, California, United States

Outcomes

Primary Outcomes

Weekly Utilization-Frequency

Weekly utilization of Sonu treatment, measured as the frequency or number of times used per week

Time frame: 90 days

Weekly Utilization-Duration

Weekly utilization of Sonu treatment, measured as the duration of treatment received per week

Time frame: 90 days

Secondary Outcomes

Total Nasal Symptom Score (TNSS)

24-hour TNSS; Minimum score=0 (no symptoms), Maximum score=12 (severe symptoms). Lower scores are better and reflect less symptoms.

Time frame: 90 days

Asthma Control

Asthma Control Test (ACT) Score; Minimum score = 5 (poor control of asthma). Maximum score = 25 (complete control of asthma). Higher scores reflect greater asthma control.

Time frame: 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.